November 8, 2004
Nov. 8, 2004 - Natural Products Industry INSIDER
"Weight Management" References
1. Bray GA. "Obesity is a chronic, relapsing neurochemicaldisease." Int J Obes Relat Metab Disord. 28, 1:34-8, 2004. www-us.ebsco.com/online/OnlineTitles.asp
2. Kruger J et al. "Attempting to lose weight: specific practices amongU.S. adults." Am J Prev Med. 26, 5:402-6, 2004. www.sciencedirect.com/science/journal/07493797
3. Avenell A et al. "What are the long-term benefits of weight reducingdiets in adults? A systematic review of randomized controlled trials." JHum Nutr Diet. 17, 4:317-35, 2004. www.blackwell-science.com
4. Anderson JW, Luan J, Hoie LH. "Structured weight-loss programs:meta-analysis of weight loss at 24 weeks and assessment of effects ofintervention intensity." Adv Ther. 21, 2:61-75, 2004.
5. Hannum SM et al. "Use of portion-controlled entrees enhances weightloss in women." Obes Res. 12, 3:538-46, 2004. www.amedeo.com/medicine/obe/obesres.htm
6. Noakes M et al. "Meal replacements are as effective as structuredweight-loss diets for treating obesity in adults with features of metabolicsyndrome." J Nutr. 134, 8:1894-9, 2004. www.nutrition.org
7. Rothacker DQ, Watemberg S. "Short-term hunger intensity changesfollowing ingestion of a meal replacement bar for weight control." Int JFood Sci Nutr. 55, 3:223-6, 2004. www.medbioworld.com/bio/journals/food.html
8. Buchholz AC, Schoeller DA. "Is a calorie a calorie?" Am JClin Nutr. 79, 5:899S-906S, 2004. www.ajcn.org
9. Astrup A, Meinert Larsen T, Harper A. "Atkins and otherlow-carbohydrate diets: hoax or an effective tool for weight loss?" Lancet.364, 9437:897-9, 2004. www.thelancet.com
10. Halton TL, Hu FB. "The effects of high protein diets onthermogenesis, satiety and weight loss: a critical review." J Am CollNutr. 23, 5:373-85, 2004. www.am-coll-nutr.org/jacn/jacn.htm
11. Westerterp-Plantenga MS. "The significance of protein in food intakeand body weight regulation." Curr Opin Clin Nutr Metab Care. 6,6:635-8, 2003. www.co-clinicalnutrition.com
12. Due A et al. "Effect of normal-fat diets, either medium or high inprotein, on body weight in overweight subjects: a randomized 1-year trial."Int J Obes Relat Metab Disord. 28, 10:1283-90, 2004. www-us.ebsco.com/online/OnlineTitles.asp
13. Johnston CS, Tjonn SL, Swan PD. "High-protein, low-fat diets areeffective for weight loss and favorably alter biomarkers in healthyadults." J Nutr. 134, 3:586-91, 2004. www.nutrition.org
14. Westerterp-Plantenga MS et al. "High protein intake sustains weightmaintenance after body weight loss in humans." Int J Obes Relat MetabDisord. 28, 1:57-64, 2004. www-us.ebsco.com/online/OnlineTitles.asp
15. Bowen J, Noakes M, Clifton PM. "High dairy-protein versus highmixed-protein energy restricted diets--the effect on bone turnover and calciumexcretion in overweight adults." Asia Pac J Clin Nutr. 12 Suppl:S52,2003.
16. Bowen J, Noakes M, Clifton PM. "A high dairy protein, high-calciumdiet minimizes bone turnover in overweight adults during weight loss." JNutr. 134, 3:568-73, 2004. www.nutrition.org
17. Deibert P et al. "Weight loss without losing muscle mass inpre-obese and obese subjects induced by a high-soy-protein diet." Int JObes Relat Metab Disord. 28, 10:1349-52, 2004. www-us.ebsco.com/online/OnlineTitles.asp
18. Aoyama T et al. "Soy protein isolate and its hydrolysate reduce bodyfat of dietary obese rats and genetically obese mice (yellow KK)." Nutrition.16, 5:349-54, 2000. www.elsevier.com/locate/nut
19. Layman DK, Baum JI. "Dietary protein impact on glycemic controlduring weight loss." J Nutr. 134, 4:968S-73S, 2004. www.nutrition.org
20. Ventrucci G et al. "Effects of a leucine-rich diet on bodycomposition during nutritional recovery in rats." Nutrition. 20,2:213-7, 2004. www.elsevier.com/locate/nut
21. Patterson BW et al. "Regional muscle and adipose tissue amino acidmetabolism in lean and obese women." Am J Physiol Endocrinol Metab.282, 4:E931-6, 2002. http://ajpendo.physiology.org
22. Flakoll P et al. "Effect of beta-hydroxy-beta-methylbutyrate,arginine and lysine supplementation on strength, functionality, body compositionand protein metabolism in elderly women." Nutrition. 20, 5:445-51,2004. www.elsevier.com/locate/nut
23. Breum L et al. "Twenty-four-hour plasma tryptophan concentrationsand ratios are below normal in obese subjects and are not normalized bysubstantial weight reduction." Am J Clin Nutr. 77, 5:1112-8, 2003. www.ajcn.org
24. Zemel MB. "Role of calcium and dairy products in energy partitioningand weight management." Am J Clin Nutr. 79, 5:907S-912S, 2004. www.ajcn.org
25. Cifuentes M et al. "Weight loss and calcium intake influence calciumabsorption in overweight postmenopausal women." Am J Clin Nutr. 80,1:123-30, 2004. www.ajcn.org
26. Rosell M et al. "Associations between the intake of dairy fat andcalcium and abdominal obesity." Int J Obes Relat Metab Disord. Aug24, 2004 [epub ahead of print]. www-us.ebsco.com/online/OnlineTitles.asp
27. Soares MJ, Binns C, Lester L. "Higher intakes of calcium areassociated with lower BMI and waist circumference in Australian adults: anexamination of the 1995 National Nutrition Survey." Asia Pac J Clin Nutr.13 Suppl:S85, 2004.
28. Loos RJ et al. "Calcium intake is associated with adiposity in blackand white men and white women of the HERITAGE Family Study." J Nutr.134, 7:1772-8, 2004. www.nutrition.org
29. Zemel MB et al. "Calcium and dairy acceleration of weight and fatloss during energy restriction in obese adults." Obes Res. 12,4:582-90, 2004. www.amedeo.com/medicine/obe/obesres.htm
30. Jensen LB et al. "Bone minerals changes in obese women during amoderate weight loss with and without calcium supplementation." J BoneMiner Res. 16, 1:141-7, 2001. www.jbmr-online.org
31. Lelovics Z. "Relation between calcium and magnesium intake andobesity." Asia Pac J Clin Nutr. 13 Suppl:S144, 2004.
32. Lenz TL, Hamilton WR. "Supplemental products used for weightloss." J Am Pharm Assoc (Wash DC). 44, 1:59-67, 2004.
33. Pittler MH, Ernst E. "Dietary supplements for body-weight reduction:a systematic review." Am J Clin Nutr. 79, 4:529-36, 2004. www.ajcn.org
34. Heber D. "Herbal preparations for obesity: are they useful?" PrimCare. 30, 2:441-63, 2003.
35. McCarty MF. "Hepatothermic therapy of obesity: rationale and aninventory of resources." Med Hypotheses. 57, 3:324-36, 2001. www.harcourt-international.com/journals/mehy
36. Owen KQ et al. "Dietary L-carnitine suppresses mitochondrialbranched chain keto acid dehydrogenase activity and enhances protein accretionand carcass characteristics of swine." J Anim Sci. 79, 12:3104-12,2001.
37. Wutzke KD, Lorenz H. "The effect of L-carnitine on fat oxidation,protein turnover, and body composition in slightly overweight subjects." Metabolism.53, 8:1002-6, 2004.
38. Muller DM et al. " Effects of oral L-carnitine supplementation on invivo long-chain fatty acid oxidation in healthy adults." Metabolism.51, 11:1389-91, 2002.
39. Saldanha Aoki M et al. "Carnitine supplementation fails to maximizefat mass loss induced by endurance training in rats." Ann Nutr Metab.48, 2:90-4, 2004. www.karger.com/anm
40. Brandsch C, Eder K. "Effect of L-carnitine on weight loss and bodycomposition of rats fed a hypocaloric diet." Ann Nutr Metab. 46,5:205-10, 2002. www.karger.com/anm
41. Kalmann DS et al. "A randomized, double blind, placebo-controlledstudy of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy overweightadults." Curr Ther Res. 61, 7:435-42, 2000. www.currenttherapeuticres.com
42. Zenk JL et al. "The effect of 7-Keto Naturalean<\#170> onweight loss: a randomized, double blind, placebo-controlled trial." CurrTher Res. 63, 4:263-72, 2002. www.currenttherapeuticres.com
43. Rainer L, Heiss CJ. "Conjugated linoleic acid: health implicationsand effects on body composition." J Am Diet Assoc. 104, 6:963-8,2004. www.eatright.org/journal
44. Terpstra AH. "Effect of conjugated linoleic acid on body compositionand plasma lipids in humans: an overview of the literature." Am J ClinNutr. 79, 3:352-61, 2004. www.ajcn.org
45. Larsen TM, Toubro S, Astrup A. "Efficacy and safety of dietarysupplements containing CLA for the treatment of obesity: evidence from animaland human studies." J Lipid Res. 44, 12:2234-41, 2003.
46. Riserus U, Berglund L, Vessby B. "Conjugated linoleic acid (CLA)reduced abdominal adipose tissue in obese middle-aged men with signs of themetabolic syndrome: a randomized controlled trial." Int J Obesity.25:1129-35, 2001. www.nature.com/ijo
47. Blankson H et al. "Conjugated linoleic acid reduces body fat mass inoverweight and obese humans." J Nutr. 130:2943-8, 2000. www.nutrition.org
48. Gaullier JM et al. "Conjugated linoleic acid supplementation for 1 yreduces body fat mass in healthy overweight humans." Am J Clin Nutr.79:1118-25, 2004. www.ajcn.org
49. Juturu V, Komorowski JR. "Evaluation of beneficial effects ofchromium picolinate and conjugated linoleic acid combination for metabolicsyndrome." Presented at the World Congress on Insulin Resistance Syndrome.
50. Vincent JB. "The potential value and toxicity of chromium picolinateas a nutritional supplement, weight loss agent and muscle developmentagent." Sports Med. 33, 3:213-30, 2003.
51. Campbell WW et al. "Effects of resistance training and chromiumpicolinate on body composition and skeletal muscle in older men." J ApplPhysiol. 86, 1:29-39, 1999. http://jap.physiology.org
52. Crawford V, Scheckenbach R, Preuss HG. "Effects of niacin-boundchromium supplementation on body composition in overweight African-Americanwomen." Diabetes Obes Metab. 1, 6:331-7, 1999. www.blackwell-synergy.com
53. Preuss HG et al. "Efficacy of a novel, natural extract of(-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX, niacin-boundchromium and Gymnema sylvestre extract in weight management in human volunteers:a pilot study." Nutr Res. 24:45-58, 2004. www.elsevier.nl/locate/nutres
54. Preuss HG et al. "Effects of a natural extract of (-)-hydroxycitricacid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnemasylvestre extract on weight loss." Diabetes Obes Metab. 6, 3:171-80,2004. www.blackwell-synergy.com
55. Jena BS et al. "Chemistry and biochemistry of (-)-hydroxycitric acidfrom Garcinia." J Agric Food Chem. 50, 1:10-22, 2002. http://pubs.acs.org/journals/jafcau
56. Roy S et al. "Body weight and abdominal fat gene expression profilein response to a novel hydroxycitric acid-based dietary supplement." GeneExpr. 11, 5-6:251-62, 2004.
57. Preuss HG et al. Study presented at the 34th Annual Meeting of theSociety of Toxicology, Baltimore, March 23, 2004.
58. Hasegawa N. "Garcinia extract inhibits lipid droplet accumulationwithout affecting adipose conversion in 3T3-L1 cells." Phytother Res.15, 2:172-3, 2001. www.interscience.wiley.com/jpages/0951-418X
59. Shara M et al. "Physico-chemical properties of a novel(-)-hydroxycitric acid extract and its effect on body weight, selected organweights, hepatic lipid peroxidation and DNA fragmentation, hematology andclinical chemistry, and histopathological changes over a period of 90days." Mol Cell Biochem. 260, 1-2:171-86, 2004. www.wkap.nl
60. Preuss HG et al. "Citrus aurantium as a thermogenic,weight-reduction replacement for ephedra: an overview." J Med. 33,1-4:247-64, 2002. www.medical-library.org/j_med.htm
61. Pathak B et al. Thermic effect of citrus aurantium in obese subjects.U.S. Patent #6,224,873. www.nutratechinc.com.
62. Colker CM et al. "Effects of Citrus aurantium extract, caffeine andSt. John's wort on body fat loss, lipid levels and mood states in overweighthealthy adults." Curr Ther Res. 60, 3:145-53, 1999. www.currenttherapeuticres.com.
63. Michna L et al. "Stimulatory effect of oral administration of greentea and caffeine on locomotor activity in SKH-1 mice." Life Sci. 73,11:1383-92, 2003. www.sciencedirect.com/science/journal/00243205
64. Wolfram S et al. "TEAVIGO improves efficacy of the PPAR[gamme]agonist rosiglitazone but inhibits associated adiposity in db/db mice."Presented at Experimental Biology, Washington, April 18, 2004. www.eb2004-online.com/viewabstract.php?id=1068
65. Chow HH et al. "Pharmacokinetics and safety of green tea polyphenolsafter multiple-dose administration of epigallocatechin gallate and polyphenon Ein healthy individuals." Clin Cancer Res. 9, 9:3312-9, 2003.
66. Zheng G et al. "Anti-obesity effects of three major components ofgreen tea, catechins, caffeine and theanine, in mice." In Vivo.18:55-62, 2004. www.iiar-anticancer.org/index2.htm
67. "A patented phytonutrient for weight management by promoting leanbody mass." Company research from Sabinsa Corp., 1999. www.sabinsa.com
68. Krieder R et al. "Effects of Coleus forskohlii extractsupplementation on body composition and markers of health in sedentaryoverweight female." Company research from Sabinsa Corp., 2002. www.sabinsa.com
69. Hayashi T et al. "Ellagitannins from Lagerstroemia speciosa asactivators of glucose transport in fat cells." Planta Med. 68,2:173-5, 2002.
70. Liu F et al. "An extract of Lagerstroemia speciosa L. hasinsulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitoryactivities in 3T3-L1 cells." J Nutr. 131, 9:2242-7, 2001. www.nutrition.org
71. Suzuki Y et al. "Antiobesity activity of extracts from Lagerstroemiaspeciosa L. leaves on female KK-Ay mice." J Nutr Sci Vitaminol (Tokyo).45, 6:791-5, 1999. http://eishoku.bcasj.or.jp/journal-e.html
72. Zahorska-Markiewicz B et al. "[Effect of chitosan in complexmanagement of obesity.]" Pol Merkuriusz Lek. 13, 74:129-32, 2002.
73. Mhurchu CN et al. "The effect of the dietary supplement, chitosan,on body weight: a randomized controlled trial in 250 overweight and obeseadults." Int J Obes Relat Metab Disord. 28, 9:1149-56, 2004. www-us.ebsco.com/online/OnlineTitles.asp
74. Gades MD, Stern JS. "Chitosan supplementation and fecal fatexcretion in men." Obes Res. 11, 5:683-8, 2003. www.amedeo.com/medicine/obe/obesres.htm
75. "Pilot clinical study of NeOpuntia<\#168> on fatbinding." Presented at Annual Conference on Weight Loss Ingredients Paris.SFA May 2004.
76. Smeets-Peeters MJE, Minekus M. "Fat binding capacity of NeOpuntiaduring passage through a dynamic gastrointestinal model." Presented atVitaFoods May 2001.
77. Udani J, Hardy M, Madsen DC. "Blocking carbohydrate absorption andweight loss: a clinical trial using Phase 2 brand proprietary fractionated whitebean extract." Altern Med Rev. 9, 1:63-9, 2004. www.thorne.com/altmedrev
You May Also Like